TransMedics (TMDX) Gross Profit Growth (3y) (2021 - 2026)
TransMedics (TMDX) Gross Profit Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn | 3.15% |
| 10 | TransMedics | 2.56 Bn | 2.10 Bn | 101.16 Mn | 52.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.07% |
| Dec 31, 2025 | 65.24% |
| Sep 30, 2025 | 67.14% |
| Jun 30, 2025 | 88.81% |
| Mar 31, 2025 | 93.89% |
| Dec 31, 2024 | 117.63% |
| Sep 30, 2024 | 152.65% |
| Jun 30, 2024 | 131.41% |
| Mar 31, 2024 | 131.85% |
| Dec 31, 2023 | 114.91% |
| Sep 30, 2023 | 100.59% |
| Jun 30, 2023 | 167.99% |
| Mar 31, 2023 | 80.89% |
| Dec 31, 2022 | 76.88% |
| Sep 30, 2022 | 62.57% |
| Jun 30, 2022 | 62.68% |
| Mar 31, 2022 | 67.56% |
| Dec 31, 2021 | 67.04% |
| Sep 30, 2021 | 20.96% |
| Jun 30, 2021 | 67.99% |